Tesamorelin 10mg

Q: What is Tesamorelin peptide used for?

To model GH release, fat breakdown, and IGF-1 signaling in cell and animal research settings.

Q: How does Tesamorelin trigger GH release?

It binds pituitary GHRH receptors to induce predictable GH pulses of ~ 30–60 minutes.

Q: What benefits does Tesamorelin show in fat-cell assays?

Increases hormone-sensitive lipase activity and free-fatty-acid release for lipolysis modeling.

Q: What dose of Tesamorelin is typical in vitro?

Concentrations range from 100 nM to 1 µM, adjusted per cell type and endpoint.

Q: How is Tesamorelin reconstituted?

Dissolve in Sterile Water for Injection or Bacteriostatic Water, mix gently, and use immediately or store at 2–8 °C.

Q: What storage conditions are required?

Store lyophilized vials at – 20 °C; use reconstituted peptide within 7 days at 2–8 °C.

Q: Does Tesamorelin affect other hormones?

No significant cortisol or prolactin elevation—data reflect GH-specific effects only.

Q: Can Tesamorelin be combined with other peptides?

Yes, it’s often co-studied with secretagogues like Ipamorelin or CJC-1295 for synergistic GH-axis modulation.

Q: Is Tesamorelin approved for therapeutic use?

Is Tesamorelin approved for therapeutic use?

Q: Where can I buy Tesamorelin injections?

Real Peptides offers ISO-certified, USA-manufactured Tesamorelin (10 mg), ≥ 99% purity, and low endotoxin—available for research use only.

$95.00

99% Pure | USA Made | Multi Dose Tesamorelin is a lab-grade GHRH analog designed to deliver clean, repeatable growth-hormone (GH) pulses in cell-based and rodent models. By mimicking your body’s natural GHRH but resisting rapid breakdown, Tesamorelin injections enable precise studies of fat-metabolism, IGF-1 activation, and endocrine-feedback loops. Each 10 mg vial is USA-manufactured under ISO standards, HPLC-verified to ≥ 99% purity, and endotoxin-screened (< 0.1 EU/mg).

What Is Tesamorelin Peptide?

Tesamorelin is a synthetic, 44-amino-acid peptide analog of human growth-hormone releasing hormone (GHRH). Engineered for enhanced stability, it resists enzymatic degradation to produce predictable, short-duration GH pulses that mimic natural endocrine rhythms. In research, Tesamorelin peptide is used to investigate how GH influences fat breakdown, muscle anabolism, and IGF-1-mediated cell signaling—all without the prolonged half-life or off-target effects of other secretagogues.

Why Choose Tesamorelin?

Researchers choose Tesamorelin when they require precise control over growth-hormone release to model metabolic and endocrine pathways without confounding variables. Tesamorelin injections deliver robust, short-lived GH surges that align closely with physiological pulses, enabling clear measurement of downstream effects on lipolysis and IGF-1 production. Produced in ISO-certified facilities and verified to ≥ 99% purity with stringent endotoxin screening, Tesamorelin ensures data consistency across both in vitro and in vivo studies. Whether your focus is adipocyte metabolism, lean-mass regulation, or pituitary feedback loops, Tesamorelin’s reproducible performance and straightforward handling make it an essential reagent for high-impact research.

What Sets Tesamorelin Apart?

Tesamorelin stands out from other GH-releasing agents by combining potent receptor engagement with a half-life optimized for research applications. Its 44-residue design enhances stability just enough to generate clean GH peaks—yet clears rapidly to avoid receptor desensitization or off-target hormone elevations such as cortisol or prolactin. This unique pharmacokinetic profile allows researchers to dissect GH-IGF-1-lipolysis pathways with unprecedented temporal resolution. From high-throughput cell assays to longitudinal rodent models, Tesamorelin’s proven reliability and minimal hormonal “noise” set a new standard for GH-axis and metabolic-health studies.